It indicated that the combination of serum PTX3 level and anti-PTX3 auto-antibodies could predict lupus nephritis activity better, not the whole SLE disease activity as the SLEDAI scores were comparable between the two groups. The gene discussed is PTX3; the disease is systemic lupus erythematosus.